NCT04815746

Brief Summary

The purpose of this research is to evaluate a new, web-based program among patients with pancreatic cancer aimed at reducing psychosocial stress.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 25, 2021

Completed
3.5 years until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 8, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 8, 2024

Completed
Last Updated

November 26, 2024

Status Verified

November 1, 2024

Enrollment Period

7 days

First QC Date

March 22, 2021

Last Update Submit

November 22, 2024

Conditions

Keywords

Psychosocial Symptom ManagementeHealth Intervention

Outcome Measures

Primary Outcomes (6)

  • Health Related Quality of Life as Measured by Perceived Stress Scale

    Perceived Stress Scale (Scale of 1-40 with higher scores indicating higher stress)

    Up to 10 weeks.

  • Health Related Quality of Life as Measured by University of California, Los Angeles (UCLA) Loneliness Scale

    UCLA Loneliness Scale (Scale of 20-80 with higher scores indicating higher loneliness)

    Up to 10 weeks.

  • Health Related Quality of Life as Measured by Interpersonal Support Evaluation List

    Interpersonal Support Evaluation List (12 item questionnaire evaluated on a 4-point Likert scale with a higher score indicating higher support).

    Up to 10 weeks.

  • Health Related Quality of Life as Measured by Functional Assessment of Cancer Therapy General - 7 Item Version (FACT-G7)

    FACT-G7 (Scale of 0-28 with higher scores indicating better quality of life)

    Up to 10 weeks.

  • Health Related Quality of Life as Measured by Functional Assessment of Cancer Therapy (FACT) Hepatobiliary-Pancreatic Symptom Index (FHSI)-18

    FACT FHSI-18 (Scale of 0-72 with lower scores indicating better quality of life)

    Up to 10 weeks.

  • The Gastrointestinal Symptom Rating Scale (GSRS)

    GSRS (Scale of 0-78 with higher scores indicating worse gastrointestinal symptoms)

    Up to 10 weeks.

Study Arms (2)

Psychosocial Symptom Management Intervention (PSMI) Experimental Condition Arm

EXPERIMENTAL

Participants in this group will receive the Cognitive Behavioral Therapy (CBT)-based skills over a 10-week period.

Behavioral: Cognitive Behavioral Therapy (CBT)-based skills

Usual Clinical Care Control Arm

ACTIVE COMPARATOR

Participants in this group will receive standard education.

Behavioral: Standard Education

Interventions

The CBT skills target reducing anxiety, (e.g., relaxation), changing negative appraisals (e.g., cognitive restructuring), coping skills training (e.g., enhancing adaptive skills), behavioral activation, interpersonal skills (e.g., communication skills) and building or enhancing social networks. The intervention will be administered online, and each module will last about 1-hour.

Psychosocial Symptom Management Intervention (PSMI) Experimental Condition Arm

Patients randomized to standard clinical care will receive standard education based on various resources (e.g., National Cancer Institute) relevant to pancreatic cancer.

Usual Clinical Care Control Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Greater than 18 years of age
  • Spanish or English speaker with ability to read one of these languages
  • Diagnosis of pancreatic cancer .
  • Willingness to be assessed at diagnosis, during neoadjuvant chemotherapy (if applicable), preoperatively (if applicable - unless time of diagnosis is preoperative visit), and postoperatively for up to two years following surgery.

You may not qualify if:

  • Patients unable to read Spanish or English, as they will be unable to complete surveys.
  • History of previous invasive cancer or treatment with chemotherapy, as they may have a different baseline functional status, quality of life, and gastrointestinal function compared to the normal healthy population, per principal investigator discretion, based on a case-by-case review.
  • Prior inpatient psychiatric treatment for severe mental illness or overt signs of severe psychopathology (e.g., psychosis) within the past six months as these conditions can interfere with adequate participation in assessments, per principal investigator discretion, based on a case-by-case review.
  • Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33136, United States

Location

MeSH Terms

Conditions

Stress, Psychological

Interventions

Cognitive Behavioral Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Frank Penedo, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 22, 2021

First Posted

March 25, 2021

Study Start

October 1, 2024

Primary Completion

October 8, 2024

Study Completion

October 8, 2024

Last Updated

November 26, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations